C14ORF102 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.77635683940025E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.2419000272601E-09 |
Normal-vs-Stage2 |
5.87050408284995E-11 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.65134572682746E-12 |
Stage1-vs-Stage2 |
1.157650E-02 |
Stage1-vs-Stage3 |
1.750190E-04 |
Stage1-vs-Stage4 |
7.012100E-04 |
Stage2-vs-Stage3 |
9.916400E-01 |
Stage2-vs-Stage4 |
7.663600E-01 |
Stage3-vs-Stage4 |
6.770400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
2.067700E-02 |
Normal-vs-Asian |
1.271240E-01 |
Caucasian-vs-AfricanAmerican |
1.400940E-03 |
Caucasian-vs-Asian |
8.194500E-02 |
AfricanAmerican-vs-Asian |
9.777800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.33066907387547E-16 |
Normal-vs-Female |
1.62829971728229E-10 |
Male-vs-Female |
2.368100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.61094999999722E-05 |
Normal-vs-Age(41-60Yrs) |
2.10550465951087E-11 |
Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
Normal-vs-Age(81-100Yrs) |
1.12639999549913E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.467000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.333400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.185600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.720200E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.293700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.297800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.024800E-01 |
Normal-vs-Grade 2 |
1.87849957811181E-10 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.63180580159406E-12 |
Grade 1-vs-Grade 2 |
4.427900E-04 |
Grade 1-vs-Grade 3 |
3.29439999946501E-07 |
Grade 1-vs-Grade 4 |
5.20940000026116E-07 |
Grade 2-vs-Grade 3 |
2.218300E-03 |
Grade 2-vs-Grade 4 |
5.095600E-03 |
Grade 3-vs-Grade 4 |
4.871200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63713487211226E-12 |
Normal-vs-ccB subtype |
1.78879133727605E-12 |
ccA subtype-vs-ccB subtype |
6.103000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.69875224997895E-12 |
Normal-vs-N1 |
1.57320001470396E-09 |
N0-vs-N1 |
3.000200E-02 |
|
|